- Home
- PLSE vs INVA Comparison
PLSE vs INVA Comparison
Compare PLSE & INVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PLSE | INVA |
|---|---|---|
| Founded | 2014 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 1.7B |
| IPO Year | 2015 | 2000 |
Fundamental Metrics
Financial Performance| Metric | PLSE | INVA |
|---|---|---|
| Price | $25.47 | $21.63 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 1 | 5 |
| Target Price | $22.00 | ★ $32.80 |
| AVG Volume (30 Days) | 328.8K | ★ 530.3K |
| Earning Date | 05-07-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 816.67 |
| EPS | N/A | ★ 2.22 |
| Revenue | N/A | ★ $217,217,000.00 |
| Revenue This Year | $840.00 | $8.95 |
| Revenue Next Year | $287.54 | $12.65 |
| P/E Ratio | ★ N/A | $9.82 |
| Revenue Growth | N/A | ★ 62.63 |
| 52 Week Low | $12.56 | $16.52 |
| 52 Week High | $27.98 | $25.15 |
Technical Indicators
Market Signals| Indicator | PLSE | INVA |
|---|---|---|
| Relative Strength Index (RSI) | 59.41 | 35.06 |
| Support Level | $17.58 | $20.56 |
| Resistance Level | $26.30 | $22.76 |
| Average True Range (ATR) | 1.75 | 0.72 |
| MACD | 0.56 | -0.15 |
| Stochastic Oscillator | 69.75 | 8.09 |
Price Performance
Historical ComparisonAbout PLSE Pulse Biosciences Inc (DE)
Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed-Field Ablation or nsPFA technology when used to ablate cellular tissue, can be used to treat a variety of medical conditions for which an optimal solution remains unfulfilled.
About INVA Innoviva Inc.
Innoviva Inc is a company with a portfolio of royalty healthcare assets. It has three primary sets of assets: a royalty portfolio, operating assets in critical care and infectious disease, and other strategic healthcare assets. Its product offering includes Relvar/Breo/Ellipta, Anoro, Trelegy, and others.